Psyence Group Provides Corporate Update Following Succesful SPAC Spin Out Of Therapeutic Division
Psyence Biomed II Corp. ("Psyence Biomed"), the therapeutics division of Psyence Group and target business of the Business Combination, is now a wholly-owned subsidiary of NASDAQ traded PBM.